Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public ...

we've benefited from extremely strong demand in China including from the expanded indication of Gardasil 9 to the 9- to 45-year age cohort in late 2022,” she explained. “In the second quarter, however ...

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

Merck's 2025 revenue forecast fell short of Wall Street expectations, following the company's decision to temporarily halt shipments of its cancer vaccine, Gardasil, to China, CNBC reported Feb. 4.

Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak discretionary spending, a move that dented its full-year forecast and sent ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least ... adjusted earnings to range between $8.88 and $9.03 per share on $64.1 billion to $65.6 billion ...

Merck is hoping that Gardasil's expanded approval for men ages 9 to 26 in China will eventually help boost uptake of the shot. "We believe China still represents a significant long-term ...

Merck & Co. shares tumbled after the company halted shipments to China of its cancer-preventing Gardasil vaccine, a dramatic escalation to the company’s problems in the country that threatens the ...